This Edition
ARTICLE | Clinical News
BNC105: Phase II start
WIR Staff
July 13, 2009 7:00 AM UTC
This quarter, Bionomics will begin a U.S. Phase II trial to evaluate 12.6 mg/m 2 IV BNC105. ...